Drreddys Laboratories | Umsatzkosten



Cost Of Sales Veränderung Datum
ANI Pharmaceuticals USD 73.04M 7.24M 2025-03
Aurora Cannabis CAD 78.85M 891K 2024-12
Bayer EUR 5.62B 98M 2025-03
Canopy Growth CAD 50.66M 9.51M 2024-12
Cipla INR 21.89B 750.6M 2025-03
Corcept Therapeutics USD 2.4M 553K 2025-03
Drreddys Laboratories INR 34.53B 2.14B 2024-12
GlaxoSmithKline GBP 1.92B 635M 2025-03
Hikma Pharmaceutical USD 813M 39M 2024-06
Lonza CHF 1.94B 858M 2024-06
Novartis USD 3.32B 90M 2024-12
Pacira USD 34.31M 5.58M 2025-03
Prestige Brands USD 126.51M 2.76M 2025-03
Richter Gedeon HUF 69.06B 5.08B 2024-09
Sun Pharmaceuticals INR 26.37B 1.03B 2025-03
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Teva Pharmaceutical Industries USD 1.98B 132M 2025-03



Drreddys Laboratories Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.